SFTPD and interstitial lung disease: On one hand, the relationship between biomarkers with potential diagnostic value and poor prognosis in AAV-ILD is not yet clear, such as Krebs Von den Lungen-6 and surfactant protein D. On the other hand, whether antifibrotic drugs can improve the poor prognosis of AAV-ILD needs more attention in the future.